Literature DB >> 23747738

A comprehensive analysis of transfection-assisted delivery of iron oxide nanoparticles to dendritic cells.

Shinji Toki1, Reed A Omary, Kevin Wilson, John C Gore, R Stokes Peebles, Wellington Pham.   

Abstract

Polylysine (PL) has been used to facilitate dendritic cell (DC) uptake of super paramagnetic iron oxide (SPIO) nanoparticles for use in magnetic resonance imaging (MRI). In this work, we examined the effect of PL on cell toxicity and induction of cell maturation as manifested by the up-regulation of surface molecules. We found that PL became toxic to bone marrow-derived DCs (BMDCs) at the 10 μg/ml threshold. Incubation of BMDCs with 20 μg/ml of PL for 1h resulted in approximately 90% cell death. However, addition of SPIO nanoparticles rescued DCs from PL-induced death as the combination of SPIO with PL did not cause cytotoxicity until the PL concentration was 1000 μg/ml. Prolonged exposure to PL induced BMDC maturation as noted by the expression of surface molecules such as MHC class II, CD40, CCR7 and CD86. However, the combination of SPIO and PL did not induce BMDC maturation at 1h. However prolonged exposure to SPIO nanoparticles induced CD40 expression and protein expression of TNFα and KC. The data suggest that the use of PL to enhance the labeling of DCs with SPIO nanoparticles is a dedicated work. Appropriate calibration of the incubation time and concentrations of PL and SPIO nanoparticles is crucial to the development of MRI technology for noninvasive imaging of DCs in vivo. FROM THE CLINICAL EDITOR: The authors of this study present detailed data on toxicity and efficiency of polylysine-facilitated uptake of USPIO-s by dendritic cells for cell-specific MR imaging.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Dendritic cells; Iron oxide nanoparticles; Nanotechnology; Polylysine; Transfection

Mesh:

Substances:

Year:  2013        PMID: 23747738      PMCID: PMC4031028          DOI: 10.1016/j.nano.2013.05.010

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  20 in total

1.  Magnetic nanoparticles for imaging dendritic cells.

Authors:  Saho Kobukai; Richard Baheza; Jared G Cobb; Jack Virostko; Jingping Xie; Amelie Gillman; Dmitry Koktysh; Denny Kerns; Mark Does; John C Gore; Wellington Pham
Journal:  Magn Reson Med       Date:  2010-05       Impact factor: 4.668

Review 2.  Dendritic cell-based vaccines for cancer therapy.

Authors:  A Grolleau; A Sloan; J J Mulé
Journal:  Cancer Treat Res       Date:  2005

3.  Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines.

Authors:  B L Strand; T L Ryan; P In't Veld; B Kulseng; A M Rokstad; G Skjak-Brek; T Espevik
Journal:  Cell Transplant       Date:  2001       Impact factor: 4.064

4.  Migration of human dendritic cells after injection in patients with metastatic malignancies.

Authors:  M A Morse; R E Coleman; G Akabani; N Niehaus; D Coleman; H K Lyerly
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

5.  Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.

Authors:  Nona Adonai; Nora Adonai; Khoi N Nguyen; Joseph Walsh; M Iyer; Tatsushi Toyokuni; Michael E Phelps; Timothy McCarthy; Deborah W McCarthy; Sanjiv Sam Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

Review 6.  Dendritic cells: therapy and imaging.

Authors:  Wellington Pham; Saho Kobukai; Chie Hotta; John C Gore
Journal:  Expert Opin Biol Ther       Date:  2009-05       Impact factor: 4.388

Review 7.  Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts.

Authors:  M Mohty; D Olive; B Gaugler
Journal:  Leukemia       Date:  2002-11       Impact factor: 11.528

8.  Cellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of mice.

Authors:  Paula J Foster; Elizabeth A Dunn; Kristina E Karl; Jonatan A Snir; Colleen M Nycz; Alfred J Harvey; Ron J Pettis
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

9.  Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues.

Authors:  J W Kupiec-Weglinski; J M Austyn; P J Morris
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

10.  Evaluation of in vivo labelled dendritic cell migration in cancer patients.

Authors:  Ruggero Ridolfi; Angela Riccobon; Riccardo Galassi; Gianluigi Giorgetti; Massimiliano Petrini; Laura Fiammenghi; Monica Stefanelli; Laura Ridolfi; Andrea Moretti; Giuseppe Migliori; Giuseppe Fiorentini
Journal:  J Transl Med       Date:  2004-07-30       Impact factor: 5.531

View more
  11 in total

Review 1.  Future nanomedicine for the diagnosis and treatment of osteoarthritis.

Authors:  Lauren R Eichaker; Hongsik Cho; Craig L Duvall; Thomas A Werfel; Karen A Hasty
Journal:  Nanomedicine (Lond)       Date:  2014-07       Impact factor: 5.307

2.  Towards a nanoparticle-based prophylactic for maternal autoantibody-related autism.

Authors:  Amir Bolandparvaz; Rian Harriman; Kenneth Alvarez; Kristina Lilova; Zexi Zang; Andy Lam; Elizabeth Edmiston; Alexandra Navrotsky; Natalia Vapniarsky; Judy Van De Water; Jamal S Lewis
Journal:  Nanomedicine       Date:  2019-07-23       Impact factor: 5.307

Review 3.  Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation.

Authors:  Robert K DeLong; Chandler B Curtis
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-06-16

Review 4.  Engineered nanomaterial exposure and the risk of allergic disease.

Authors:  Jonathan H Shannahan; Jared M Brown
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-04

5.  Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model.

Authors:  Shawn M Barton; Vaibhav A Janve; Richard McClure; Adam Anderson; Joanne A Matsubara; John C Gore; Wellington Pham
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.160

6.  Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine.

Authors:  Bo Li; Michael Siuta; Vanessa Bright; Dmitry Koktysh; Brittany K Matlock; Megan E Dumas; Meiying Zhu; Alex Holt; Donald Stec; Shenglou Deng; Paul B Savage; Sebastian Joyce; Wellington Pham
Journal:  Int J Nanomedicine       Date:  2016-11-16

7.  Myeloid 12/15-LOX regulates B cell numbers and innate immune antibody levels in vivo.

Authors:  Sarah N Lauder; Victoria J Tyrrell; Keith Allen-Redpath; Maceler Aldrovandi; David Gray; Peter Collins; Simon A Jones; Philip R Taylor; Valerie O'Donnell
Journal:  Wellcome Open Res       Date:  2017-01-04

8.  Contribution of engineered nanomaterials physicochemical properties to mast cell degranulation.

Authors:  Monica M Johnson; Ryan Mendoza; Achyut J Raghavendra; Ramakrishna Podila; Jared M Brown
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

9.  The effect of superparamagnetic iron oxide with iRGD peptide on the labeling of pancreatic cancer cells in vitro: a preliminary study.

Authors:  Hou Dong Zuo; Wei Wu Yao; Tian Wu Chen; Jiang Zhu; Juan Juan Zhang; Yu Pu; Gang Liu; Xiao Ming Zhang
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

Review 10.  Nanoparticle Vaccines Against Infectious Diseases.

Authors:  Rashmirekha Pati; Maxim Shevtsov; Avinash Sonawane
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.